Stock COSM COSMOS HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cosmos Holdings Inc. OTC Markets

Equities

COSM

US2214131078

Pharmaceuticals

Delayed OTC Markets
Other stock markets
 11:14:35 2021-10-05 am EDT 		5-day change 1st Jan Change
4.51 USD -5.65% Intraday chart for Cosmos Holdings Inc. -2.45% -.--%
Mar. 21 Cosmos Health Inc. Commences Development of Cloudscreen 2.0 the New Iteration of Its Next Generation AI Drug Repurposing Platform CI
Mar. 18 Cosmos Health Inc. Receives Regulatory Approval to Sell Sky Premium Life Products in UAE Nutritional Supplements Market CI

Valuation

Fiscal Period: December 2022 2023 2024
Capitalization 1 48.22 10.95 10.95
Enterprise Value (EV) 1 48.22 10.95 10.95
P/E ratio -0.14 x -1.02 x -1.38 x
Yield - - -
Capitalization / Revenue - 0.21 x 0.17 x
EV / Revenue - 0.21 x 0.17 x
EV / EBITDA - -3.46 x -8.08 x
EV / FCF - - -
FCF Yield - - -
Price to Book - - -
Nbr of stocks (in thousands) 10,574 16,846 16,846
Reference price 2 4.560 0.6500 0.6500
Announcement Date 4/12/23 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024
Net sales 1 - 51.29 63.98
EBITDA 1 - -3.161 -1.355
EBIT 1 - -11.14 -8.405
Operating Margin - -21.73% -13.14%
Earnings before Tax (EBT) 1 - -7.791 -8.925
Net income 1 -13.83 -7.746 -8.525
Net margin - -15.1% -13.32%
EPS 2 -33.16 -0.6400 -0.4700
Free Cash Flow - - -
FCF margin - - -
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 4/12/23 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - 13.75 14.55 15.25 16.64 17.55
EBITDA 1 - -1.125 -0.605 -0.56 -0.33 0.14
EBIT 1 - -2.9 -2.375 -2.325 -2.09 -1.615
Operating Margin - -21.09% -16.32% -15.25% -12.56% -9.2%
Earnings before Tax (EBT) 1 - -3 -2.505 -2.455 -2.22 -1.745
Net income 1 -3.349 -2.94 -2.405 -2.355 -2.12 -1.645
Net margin - -21.38% -16.53% -15.44% -12.74% -9.37%
EPS 2 -0.2700 -0.2000 -0.1400 -0.1400 -0.1100 -0.0800
Dividend per Share - - - - - -
Announcement Date 11/20/23 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024
Net Debt - - -
Net Cash position - - -
Leverage (Debt/EBITDA) - - -
Free Cash Flow - - -
ROE (net income / shareholders' equity) - - -
ROA (Net income/ Total Assets) - - -
Assets 1 - - -
Book Value Per Share - - -
Cash Flow per Share - - -
Capex 1 - 1.3 1.75
Capex / Sales - 2.53% 2.74%
Announcement Date 4/12/23 - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.65 USD
Average target price
4 USD
Spread / Average Target
+515.38%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
MCKESSON CORPORATION Stock McKesson Corporation
+17.35% 71.39B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+2.39% 25.1B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+5.38% 8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+6.69% 8.19B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.96% 7.91B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+0.49% 4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+17.12% 4.31B
GALENICA AG Stock Galenica AG
-2.61% 3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+22.08% 3.64B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. COSM Stock
  4. COSM Stock
  5. Financials Cosmos Holdings Inc.